Egilius L.H. Spierings, M.D., Ph.D.
Founder, Medical Director, and Principal Investigator
Dr. Spierings is a physician, former clinical professor, and founder of MedVadis Research, based just outside Boston, Massachusetts. For more than 40 years, Dr. Spierings has been dedicated to understanding headaches and treating headache patients effectively. MedVadis Research is a clinical trial research center focused on headaches, including migraines, and chronic pain.
Dr. Spierings considers his work in clinical trial research as part of his goal to advance headache treatment. His involvement with clinical trial research began in 1980 while a neurology resident at the Erasmus University in Rotterdam, The Netherlands. When he moved to Boston in 1986, Dr. Spierings became the director of The Headache Research Foundation, an affiliate of Tufts University School of Medicine. In the late 1980s, Dr. Spierings worked on the first triptan known as Imitrex®, which came on the market in 1991 to treat migraines.
In addition to his clinical trial research at MedVadis and until recently, Dr. Spierings treated patients at Tufts Medical Center, where he was the director of the Headache and Face Pain Program. Dr. Spierings was also a clinical professor of neurology and craniofacial pain at Tufts University Schools of Medicine and Dental Medicine. From 1999 to 2014, Dr. Spierings was an associate clinical professor of neurology at Harvard Medical School's Brigham and Women's Hospital. In October 2019, Dr. Spierings and MedVadis Research joined Boston PainCare where Dr. Spierings continues his research and serves as Director of the Boston Headache Institute.